The Genetic And Cellular Control Of Lymphangiogenesis In Health And Disease
Funder
National Health and Medical Research Council
Funding Amount
$475,534.00
Summary
Lymphatic vessels and veins play major roles in cardiovascular disorders. In many vascular pathologies we need an ability to promote or restrict vessel formation. This research investigates the genes that control the development of new veins and lymphatic vessels. Outcomes will include a greater understanding of how our vasculature is formed, providing new knowledge that should contribute to future lymphatic and vascular therapeutic approaches.
Patient-specific Modelling Of Cardiovascular Disease
Funder
National Health and Medical Research Council
Funding Amount
$428,065.00
Summary
Cardiovascular disease is undoubtedly the biggest killer in the developed world and accounts for 30% of all deaths in Australia; killing one Australian every twelve minutes. My research group and I, combine medical imaging with biomedical engineering to perform patient-specific modelling. For example, we can predict the likelihood that aneurysm will rupture or the way blood flows through the aorta. My goal is to make these modelling tools accurate and robust enough to be used in the clinic.
The Molecular Determinants Of Immunological Tolerance
Funder
National Health and Medical Research Council
Funding Amount
$473,477.00
Summary
Autoimmune diseases, such as type I diabetes and multiple sclerosis, are debilitating disorders that impose a massive toll on wellbeing in Australia and worldwide. This fellowship will support research aimed at determining the genes and mechanisms that control autoimmunity. New technologies will be brought to bear to track immune cells throughout their development, maturity and malfunction in disease settings. We aim to uncover new therapeutic targets to prevent and reverse autoimmune disease.
This application proposes to study in detail the main target cell for HIV infection, namely CCR5+ CD4 T lymphocytes. After 30 years of the pandemic, fundamental knowledge of these cells, such as locations in the body, differentiation from other lymphocytes, and survival, is still lacking. These attributes determine whether or not they will be infected by HIV, whether this can be prevented by vaccines or CCR5 blocking drugs, and whether their long-term survival results in an inability to eradicat ....This application proposes to study in detail the main target cell for HIV infection, namely CCR5+ CD4 T lymphocytes. After 30 years of the pandemic, fundamental knowledge of these cells, such as locations in the body, differentiation from other lymphocytes, and survival, is still lacking. These attributes determine whether or not they will be infected by HIV, whether this can be prevented by vaccines or CCR5 blocking drugs, and whether their long-term survival results in an inability to eradicate HIV.Read moreRead less